ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
다우존스 지수
43,487.83
0.78%
Bitcoin
103,627.47
-0.48%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Sage Therapeutics Inc (SAGE) 시세

Sage Therapeutics Inc

Sage Therapeutics Inc (SAGE)

Sage Potash Corp
7.08
0.11
(1.58%)
마감 18 1월 6:00AM
15분 지연
7.2995
0.2195
(3.10%)
시간외 거래: 9:59AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
7.08
매수가
6.83
매도가
7.30
거래량
4,917,688
6.88 일간 변동폭 7.188
4.62 52주 범위 27.675
market_cap
433.107M
전일 종가
6.97
개장가
7.02
최근 거래 시간
662660
@
7.08
(average)
마지막 거래 시간
재정 규모
US$ 34,436,164
VWAP
7.0025
평균 볼륨(3m)
1,539,882
발행 주식
61,173,263
배당수익률
-
주가수익률
-0.80
주당순이익(EPS)
-8.85
매출
86.46M
순이익
-541.49M

Sage Therapeutics Inc 정보

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.sagerx.com
본부
Wilmington, Delaware, USA
설립됨
-
Sage Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SAGE. The last closing price for Sage Therapeutics was US$6.97. Over the last year, Sage Therapeutics shares have traded in a share price range of US$ 4.62 to US$ 27.675.

Sage Therapeutics currently has 61,173,263 shares in issue. The market capitalisation of Sage Therapeutics is US$426.38 million. Sage Therapeutics has a price to earnings ratio (PE ratio) of -0.80.

SAGE 최신 뉴스

추가 뉴스

Sage Therapeutics to Present 2025 Strategic Focus at 43rd Annual J.P. Morgan Healthcare Conference

Increased investment in ZURZUVAE to help accelerate market growth in postpartum depression with the goal of topline revenue growth in 2025 R&D and G&A expenses expected to decrease...

13 1월 2025
Business Wire

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen

No Shareholder Action Required at This Time Sage Therapeutics, Inc. (Nasdaq: SAGE) (“The Company”), today confirmed that Biogen Inc. (Nasdaq: BIIB) (“Biogen”) has submitted to the Company an...

11 1월 2025
Business Wire

Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025

Sage Therapeutics, Inc. (NASDAQ: SAGE) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025, at 8:15 a.m. PT in San...

08 1월 2025
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

28 12월 2024
Edgar (US Regulatory)

Form 8-K - Current report

27 11월 2024
Edgar (US Regulatory)

Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Sage Therapeutics, Inc. (NASDAQ: SAGE), today announced that the Company will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024...

26 11월 2024
Business Wire

Form 8-K - Current report

20 11월 2024
Edgar (US Regulatory)

Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease

The Phase 2 DIMENSION Study did not meet its primary endpoint Dalzanemdor was generally well-tolerated; no new safety signals were observed Based on these data, the Company does not plan further...

20 11월 2024
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

15 11월 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

09 11월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.41524.97793468675.6657.885.44556377547.22554838CS
42.0239.92094861665.067.884.9529036796.55623809CS
12-0.81-10.26615969587.898.74.6215398826.20299313CS
26-4.93-41.049125728612.0113.474.6210713287.07564131CS
52-18.92-72.76923076922627.6754.62108732311.54511937CS
156-35.26-83.278223901742.3459.994.6288845123.80937921CS
260-67.42-90.496644295374.598.3854.6282390634.44637956CS

SAGE - Frequently Asked Questions (FAQ)

What is the current Sage Therapeutics share price?
The current share price of Sage Therapeutics is US$ 7.08
How many Sage Therapeutics shares are in issue?
Sage Therapeutics has 61,173,263 shares in issue
What is the market cap of Sage Therapeutics?
The market capitalisation of Sage Therapeutics is USD 426.38M
What is the 1 year trading range for Sage Therapeutics share price?
Sage Therapeutics has traded in the range of US$ 4.62 to US$ 27.675 during the past year
What is the PE ratio of Sage Therapeutics?
The price to earnings ratio of Sage Therapeutics is -0.8
What is the cash to sales ratio of Sage Therapeutics?
The cash to sales ratio of Sage Therapeutics is 5
What is the reporting currency for Sage Therapeutics?
Sage Therapeutics reports financial results in USD
What is the latest annual turnover for Sage Therapeutics?
The latest annual turnover of Sage Therapeutics is USD 86.46M
What is the latest annual profit for Sage Therapeutics?
The latest annual profit of Sage Therapeutics is USD -541.49M
What is the registered address of Sage Therapeutics?
The registered address for Sage Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Sage Therapeutics website address?
The website address for Sage Therapeutics is www.sagerx.com
Which industry sector does Sage Therapeutics operate in?
Sage Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

SAGE Discussion

게시물 보기
Monksdream Monksdream 10 월 전
SAGE over $10
👍️0
everton44 everton44 1 년 전
SAGE going to 36 dollars, every article and financial companies downgrading SAGE yet it goes up big. HAHAHA
👍️0
gail gail 1 년 전
i dont know anything about…

…

shorting. i am a simpleton, lol, i just trade like a normal trader.

not in this one, but made a bundle on my last few trades, including ttoo today. weeee!!
👍️0
everton44 everton44 1 년 전
we are all short selling the piss out of this now, come on board
👍️0
gail gail 1 년 전
so, they got approved yet…

..

it dropped huge today? im not in it but watching.
👍️0
AGORDON AGORDON 1 년 전
FDA approved Zuranolone for PPD. CRL for Major Depressive.
👍️0
AGORDON AGORDON 1 년 전
The FDA is still considering whether to approve zuranolone for clinical depression in addition to postpartum depression, but did not issue a decision on that indication.
👍️0
budgetthis budgetthis 3 년 전
I was gonna burn some SAGE today, in a therapeutic manner, like they do on Yellowstone to ward off evil spirits.

But no need……elevators going up today……lol.

$$ SAGE $$
👍️0
CjMitts CjMitts 3 년 전
Called the pump, How'd I know, garbby 10q report, RSI divergence. will be loading this at the bottom though with the money I make from this short, the potential of this companies pipeline is enormous.
👍️0
CjMitts CjMitts 3 년 전
Boom
👍️0
CjMitts CjMitts 3 년 전
Dont be fooled by the pump. Will be loading between 34-26. Surprised there's no talk on this page regarding the potential of this companies pipeline.
👍️0
thumper1 thumper1 5 년 전
im out high 68.eom
👍️0
thumper1 thumper1 5 년 전
bought 67.11. we will see
👍️0
NYCPuglet NYCPuglet 5 년 전
Sold at 77. Thank god. Lol.
👍️0
NYCPuglet NYCPuglet 5 년 전
In 1000 @ at 73. Easy profit flipper here. Very big whales behind this company.
👍️0
Daysinn4610 Daysinn4610 5 년 전
Ceo cfo cso all buying shares https://www.gurufocus.com/news/999044/sage-therapeutics-inc-sage-president--ceo-jeffrey-m-jonas-bought-481500-of-shares
👍️0
Daysinn4610 Daysinn4610 5 년 전
Some sage news https://www.streetinsider.com/dr/news.php?id=16261148
👍️0
keekee keekee 5 년 전
Lol....brig6and early. Crossing $80 today? The $125 may actually happen by the end if the month? We will see.
👍️0
keekee keekee 5 년 전
Seen this...though it is going to be just a few days apart. Congrats to BULLS....and I sure hope those that jumped in to short because I highlighted the stock GO BANKRUPT!!!
👍️0
keekee keekee 5 년 전
$74 now. Everyone that shorted past week is now in red. And it will get even more painful going forward. Sorry, losers!
👍️0
keekee keekee 5 년 전
$3 to $4 a day is fine for now. In a week or so we wi6see doing more than that number as we race back towards $125. When I saw BUY...and some.fools sell, all I think of is, Who the hell is their father!!!! Who do they get information from...David Einhorn or who? He just did 34% loss last year and is on track to be smothered again with the TSLA outperformance. We are headed up....Intelsat, SAGE, ASLN, FRAN, And a host of others.
👍️0
keekee keekee 5 년 전
We're headed to $80 very likely today. It's a one way train here m.j till.$100.
👍️0
Biobonic Biobonic 5 년 전
Post-hoc analysis revealed that in the MOUNTAIN Study, approximately 9% of patients in the SAGE-217 30 mg group had no measurable drug concentration, consistent with non-compliance in taking SAGE-217

In the 30mg group, 192 received the medication at the onset of the trial.

9% would approximate: 17 participants.

The trial had 28 participants withdraw by day 42. (14%) a significant number, especially since there was a good measure of efficacy.



👍️0
RJ Trotts RJ Trotts 5 년 전
I got out with 4.50 per share profit, we are both happy, enjoy your weekend. Hoping to find more winners next week.
👍️0
Nebuchadnezzar Nebuchadnezzar 5 년 전
Caught this falling knife yesterday, out up $6.45 profit
👍️0
keekee keekee 5 년 전
Watch when this stock went down from $68 yestersay. That was when I intentionally posted that I loaded. They came.and brought the it down. I reloaded. And they sre still here. Ditto for PTGX, 1, PRTY, AIHS, ASLN, AFH, SLDB, AFI, CBAY, ATIS. and a couple more. The have shorted most of these floats over 100% but still.manages tonhang on because folks have no idea that these stocks will fly double or triple. But check those out and good luck. They are mostly DOUBLERS in a month or two.
👍️0
keekee keekee 5 년 전
There are folks that short anything I buy. They are the idiots holding this down. CV lick on my name to see other stocks we play opposite. They have money but no brain. Investor money. They will shi ort anything I posted that I bought under any circumstance. They are the knes here. Ignote the selling and load. This will fly!!!
👍️0
T695 T695 5 년 전
I think we at resistance in the $66 are. The entire market will be over bought in a minute and this will sell off hard
👍️0
keekee keekee 5 년 전
Minimum close today will be $70. I will take that..from $54 and lower entry yesterday. This one is as easy...easy. will likely be trending toward $100 by month end
👍️0
T695 T695 5 년 전
Looks like my first outlook was the right one
👍️0
VictorMasonIsRight VictorMasonIsRight 5 년 전
SAGE test compromised by 9 non compliant patients?
Otherwise would have met all benchmarks?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152647122
👍️0
RJ Trotts RJ Trotts 5 년 전
up in pre-market right now, here's to hoping it bounces nicely
👍️0
T695 T695 5 년 전
On second thoughts, might me another 20% or so haircut today after all the downgrades
👍️0
T695 T695 5 년 전
It’s way over sold, but still could fall to 50ish
👍️0
T695 T695 5 년 전
I’m thinking we get a bounce from here to $66-67ish, when if it hits there it may either run back to low 70’s or pull back to 50’s then run to $70’s.... either way I see lows 50’s and lows 70’s as short term bottom and top
👍️0
RJ Trotts RJ Trotts 5 년 전
May add some here after hours, and see if it will bounce tomorrow. Best to all here. Hoping it is oversold!
👍️0
keekee keekee 5 년 전
Unfortunately, I brought them over..I mean the heavy sellers. These guys are blind in their rabid quest to trade against me. But I create losses for them. That is my mission now. We will see $100. The clueless sellers know it too!
👍️0
keekee keekee 5 년 전
Will cross $80 tom8. Must $100 by next week. The fools selling are misguided
👍️0
T695 T695 5 년 전
Might see by EOD
👍️0
keekee keekee 5 년 전
This thing may actually return to $1.25 by year end. That would be over 200% for.me. lol. In at $54 and lower..pre.
👍️0
keekee keekee 5 년 전
Loaded premkt at $53. Must get $100. Drug did not fail if you factor in the 9 candidates that did not take it. $100..let's go
👍️0
T695 T695 5 년 전
Make take a nibble at $50
👍️0
altruism altruism 5 년 전
4 according to 1 news source I saw
👍️0
Awl416 Awl416 5 년 전
How many billions that she’s off the market cap - wow
👍️0
NYCPuglet NYCPuglet 6 년 전
Such an easy predictable stock.
👍️0
cvm101 cvm101 6 년 전
So this Leerink Swann call of 1/7 is looking pretty idiotic now as stock crosses $144.00
Earlier they had downgraded and lowered target price to $80.00

Sage Therapeutics stock price target raised to $90 from $80 at Leerink
👍️0
NYCPuglet NYCPuglet 6 년 전
Once again it drops. Gotta love this flipper.
👍️0
NYCPuglet NYCPuglet 6 년 전
Wish I had funds last week to throw in. I sensed a big pop was coming.
👍️0
cvm101 cvm101 6 년 전
Well it has been - but with the approval to market the new drug its less a speculation and more an investable company. Longer term its worth $200. Most analyst target prices are in that area.
👍️0
NYCPuglet NYCPuglet 6 년 전
Yep. This is an insane flipper stock.
👍️0

최근 히스토리

NASDAQ
SAGE
Sage Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유